Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats

Hormones and Behavior

Volumn 56, Issue 1, 2009, Pages 35-43

  Pentkowski, Nathan S ^a,b   Litvin, Yoav ^a,b   Blanchard, D Caroline ^a,b   Vasconcellos, Amy ^a   King, Lanikea B ^a   Blanchard, Robert J ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Anxiety; Conditioning; CRF; Defense; EPM; Fear; Hippocampus; Predator; Rats; Stress

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GLUTAMIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; HIPPOCAMPUS; LONG EVANS RAT; LONG TERM EXPOSURE; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; ODOR; PREDATOR; PRIORITY JOURNAL; RAT; THREAT;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CATHETERIZATION; CATS; CONDITIONING (PSYCHOLOGY); CORTICOTROPIN-RELEASING HORMONE; HIPPOCAMPUS; MALE; MAZE LEARNING; ODORS; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 67349139864     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.02.007     Document Type: Article

References (75)

1. Apfelbach R., Blanchard D.C., Blanchard R.J., Hayes R.A., and McGregor I.S. The effects of predator odors in mammalian prey species: a review of field and laboratory studies. Neurosci. Biobehav. Rev. 29 (2005) 1123-1144
2. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
3. Bannerman D.M., Deacon R.M., Offen S., Friswell J., Grubb M., and Rawlins J.N. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav. Neurosci. 116 (2002) 884-901
4. Bannerman D.M., Grubb M., Deacon R.M.J., Yee B.K., Feldon J., and Rawlins J.N.P. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res. 139 (2003) 197-213
5. Bast T., and Feldon J. Hippocampal modulation of sensorimotor processes. Prog. Neurobiol. 70 (2003) 319-345
6. Bast T., Zhang W.-N., and Feldon J. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the GABAA agonist muscimol. Exp. Brain Res. 139 (2001) 39-52
7. Bertoglio L.J., Joca S.R.L., and Guimaraes F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav. Brain Res. 175 (2006) 183-188
8. Blanchard D.C., and Blanchard R.J. Ethoexperimental approaches to the biology of emotion. Annu. Rev. Psychol. 39 (1988) 43-68
9. Blanchard R.J., and Blanchard D.C. Antipredator defensive behaviors in a visible burrow system. J. Comp. Psychol. 103 (1989) 70-82
10. Blanchard R.J., and Blanchard D.C. An ethoexperimental analysis of defense, fear and anxiety. In: McNaughton N., and Andrews G. (Eds). Anxiety (1990), Otago University Press, Dunedin 124-133
11. Blanchard R.J., and Blanchard D.C. Bringing natural behaviors into the laboratory: a tribute to Paul MacLean. Physiol. Behav. 79 (2003) 515-524
12. Blanchard R.J., Blanchard D.C., and Hori K. An ethoexperimental approach to the study of defense. In: Blanchard R.J., Brain P.F., Blanchard D.C., and Parmigiani S. (Eds). Ethoexperimental Approaches to the Study of Behavior (1989), Kluwer Academic Publishers, Dordrecht, The Netherlands 114-136
13. Blanchard R.J., Blanchard D.C., and Weiss S.M. Ethanol effects in an anxiety/defense test battery. Alcohol 7 (1990) 375-381
14. Blanchard R.J., Blanchard D.C., Weiss S.M., and Meyer S. The effects of ethanol and Diazepam on reactions to predatory odors. Pharmacol. Biochem. Behav. 35 (1990) 775-780
15. Blanchard D.C., Blanchard R.J., Tom P., and Rodgers R.J. Diazepam changes risk assessment in an anxiety/defense test battery. Psychopharmacology (Berl.) 101 (1990) 511-518
16. Blanchard D.C., Shepherd J.K., Rodgers R.J., and Blanchard R.J. Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology (Berl.) 106 (1992) 531-539
17. Blanchard R.J., Shepherd J.K., Rodgers R.J., Magee L., and Blanchard D.C. Attenuation of Antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology (Berl.) 110 (1993) 245-253
18. Blanchard D.C., Griebel G., and Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25 (2001) 205-218
19. Blanchard D.C., Griebel G., and Blanchard R.J. The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic. Eur. J. Pharmacol. 463 (2003) 97-116
20. Blanchard D.C., Canteras N.S., Markham C.M., Pentkowski N.S., and Blanchard R.J. Lesions of structures showing FOS expression to cat presentation: effects on responsivity to a Cat, Cat odor, and nonpredator threat. Neurosci. Biobehav. Rev. 29 (2005) 1243-1253
21. Blank T., Nijholt I., Eckart K., and Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J. Neurosci. 22 (2002) 3788-3794
22. Campbell B.M., Morrison J.L., Walker E.L., and Merchant K.M. Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats. Pharmacol. Biochem. Behav. 77 (2004) 447-455
23. Canteras N.S. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol. Biochem. Behav. 71 (2002) 481-491
24. Canteras N.S., and Swanson L.W. Projections of the ventral subiculum to the amygdala, septum, and hypothalamus: a PHAL anterograde tract-tracing study of the rat. J. Comp. Neurol. 324 (1992) 180-194
25. Canteras N.S., Chiavegatto S., Ribeiro Do Valle L.E., and Swanson L.W. Severe reduction of rat defensive behavior to a predator by discrete hypothalamic chemical lesions. Brain Res. Bull. 44 (1997) 297-305
26. Canteras N.S., Ribeiro-Barbosa E.R., and Comoli E. Tracing from the dorsal premammillary nucleus prosencephalic systems involved in the organization of innate fear responses. Neurosci. Biobehav. Rev. 25 (2001) 661-668
27. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
28. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15 (1995) 6340-6350
29. Comoli E., Ribeiro-Barbosa E.R., and Canteras N.S. Afferent connections of the dorsal premammillary nucleus. J. Comp. Neurol. 423 (2000) 83-98
30. Degroot D., and Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res. 949 (2002) 60-70
31. Degroot A., and Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res. 1001 (2004) 60-71
32. Eckart K., Jahn O., Radulovic J., Tezval H., van Werven L., and Spiess J. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Proc. Natl. Acad. Sci. 98 (2001) 11142-11147
33. Gray J.A., and McNaughton N. The Neuropsychology of Anxiety. 2nd Edn (2000), Oxford University Press, Oxford
34. Griebel G., Perrault G., and Sanger D.J. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23 (1999) 81-98
35. Griebel G., Rodgers R.J., Perrault G., and Sanger D.J. Behavioural profiles in the mouse defense test battery suggest anxiolytic potential of 5-HT1A receptor antagonists. Psychopharmacology (Berl.) 144 (1999) 121-130
36. Heinrichs S.C., and Joppa M. Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav. Brain Res. 122 (2001) 43-50
37. Henry B., Vale W., and Markou A. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. J. Neurosci. 26 (2006) 9142-9152
38. Hillhouse E., and Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 27 (2006) 260-286
39. Ho S.P., Takahashi L.K., Livanov V., Spencer K., Lesher T., Maciag C., Smith M.A., Rohrbach K.W., Hartig P.R., and Arneric S.P. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Mol. Brain Res. 89 (2001) 29-40
40. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
41. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., and Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proc. Natl. Acad. Sci. 99 (2002) 10825-10830
42. Kortekaas R., Costall B., and Smythe J.W. Changes in hippocampal theta following intrahippocampal corticotropin-releasing hormone (CRH) infusions in the rat. Brain Res. Bull. 48 (1999) 603-607
43. Lee Y., and Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17 (1997) 6434-6446
44. Li C.-I., Maglinao T.L., and Takahashi L.K. Medial amygdala modulation of predator odor-induced unconditioned fear in the rat. Behav. Neurosci. 118 (2004) 324-332
45. Lowry C.A., and Moore F.L. Regulation of behavioral responses by corticotropin-releasing factor. Gen. Comp. Endocrinol. 146 (2006) 19-27
46. Markham C.M., Blanchard D.C., Canteras N.S., Cuyno C.D., and Blanchard R.J. Modulation of predatory odor processing following lesions to the dorsal premammillary nucleus. Neurosci. Lett. 372 (2004) 22-26
47. McGregor I.S., Hargreaves G.A., Apfelbach R., and Hunt G.E. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J. Neurosci. 24 (2004) 4134-4144
48. McHugh S.B., Deacon R.M., Rawlins J.N.P., and Bannerman D.M. Amygdala and ventral hippocampal lesions contribute differentially to mechanisms of fear and anxiety. Behav. Neurosci. 118 (2004) 63-78
49. McNaughton N., Kocsis B., and Hajos M. Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?. Behav. Pharmacol. 18 (2007) 329-346
50. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23 (1999) 591-613
51. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
52. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, Sydney
53. Pelleymounter M.A., Joppa M., Ling N., and Foster A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor (2) receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther. 302 (2002) 145-152
54. 2 receptor agonists urocortin II and urocortin III. Peptides 25 (2004) 659-666
55. Pentkowski N.S., Blanchard D.C., Lever C., Litvin Y., and Blanchard R.J. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. Eur. J. Neurosci. 23 (2006) 2185-2196
56. Petrovich G.D., Risold P.Y., and Swanson L.W. Organization of the projections of the basomedial nucleus of the amygdala: a PHAL study in the rat. J. Comp. Neurol. 374 (1996) 387-420
57. Petrovich G.D., Canteras N.S., and Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res. Brain Res. Rev. 38 (2001) 247-289
58. Phelps E.A., and LeDoux J.E. Contributions of the amygdala to emotional processing: from animal models to human behaviors. Neuron 48 (2005) 175-187
59. Pikkarainen M., Ronkko S., Savander V., Insausti R., and Pitkanen A. Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J. Comp. Neurol. 403 (1999) 229-260
60. Radulovic J., Ruhmann R., Liepold T., and Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19 (1999) 5016-5025
61. Richmond M.A., Yee B.K., Pouzet B., Veenman L., Rawlins J.N.P., Feldon J., and Bannerman D.M. Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. Behav. Neurosci. 113 (1999) 1189-1203
62. Risbrough V.B., Hauger R.L., Robers A.L., Vale W.W., and Geyer M.A. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 24 (2004) 6545-6552
63. Risold P.Y., and Swanson L.W. Connections of the rat lateral septal complex. Brain Res. Brain Res. Rev. 24 (1997) 115-195
64. Rosen J.B. The neurobiology of conditioned and unconditioned fear: a neurobehavioral system analysis of the amygdale. Behav. Cogn. Neurosci. Rev. 3 (2004) 23-41
65. Spiess J., Rivier J., Rivier C., and Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl. Acad. Sci. 78 (1981) 6517-6521
66. Spiga F., Lightman S.L., Shekhar A., and Lowry C.A. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience 138 (2006) 1265-1276
67. Sutton S.W., Behan D.P., Lahrichi S.L., Kaiser R., Corrigan A., Lowry P., Potter E., Perrin M.H., Rivier J., and Vale W.W. Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology 136 (1995) 1097-1102
68. Takahashi L.K. Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25 (2001) 627-636
69. Todorovic C., Jahn O., Tezval H., Hippel C., and Spiess J. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist Cortagine. Neurosci. Biobehav. Rev. 29 (2005) 1323-1333
70. Trivedi M.A., and Coover G.D. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiol. Learn. Mem. 81 (2004) 172-184
71. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W.W., and Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 943 (2002) 142-150
72. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W.W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
73. Venihaki M., Sakihara S., Subramanian S., Dikkes P., Weninger S.C., Liapakis G., Graf T., and Majzoub J.A. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J. Neuroendocrinol. 16 (2004) 411-422
74. Zhang W.-N., Bast T., and Feldon J. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-D-aspartate or in noncompetitive antagonist MK-801 into the ventral hippocampus. Behav. Brain Res. 126 (2001) 159-174
75. Zorrilla E.P., Valdez G.R., Nozulak J., Koob G.F., and Markou A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res. 952 (2002) 188-199